BIOFORCE NANOSCIENCES HOLDINGS, INC.
No SEC Form 4 filings for $BFNH in the last 30 days.
See all $BFNH insider activity →BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2026 BIOFORCE NANOSCIENCES HOLDINGS, INC. (Exact name of registran
Ferguson Merle sold 26,700,000 shares of BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) at $0.02 ($0.40M total) on 2026-04-22.
Bioforce Nanosciences Holdings (OTC: BFNH) said the U.S. Bureau of Land Management approved assignment of 11 federal oil and gas leases in Nevada’s White River Valley covering about 20,000 acres. The company plans exploration and development, including possible 3D seismic and drilling. Ryder Scott was hired on June 26, 2026 to estimate resources and NPV.
Over the past 7 days, alphai's AI scored 1 news story mentioning BFNH (BIOFORCE NANOSCIENCES HOLDINGS, INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent BFNH coverage spans corporate actions, insider activity and financial news.
The unregistered equity sale dilutes existing shareholders but raises modest capital for the company.
Significant insider sell may signal lack of confidence, potential short-term pressure on stock.
BLM approval and planned exploration are a near-term catalyst for BFNH, but economics remain unconfirmed pending technical work.
Management turnover plus a stated pivot from vitamins to oil & gas increases execution and governance risk, likely pressuring near-term sentiment.
alphai scores every news story that mentions BFNH with an AI model for sentiment and relevance, and aggregates insider trades from BIOFORCE NANOSCIENCES HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2026 BIOFORCE NANOSCIENCES HOLDINGS, INC. (Exact name of registran
1 min readFerguson Merle sold 26,700,000 shares of BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) at $0.02 ($0.40M total) on 2026-04-22.
1 min readBioforce Nanosciences Holdings (OTC: BFNH) said the U.S. Bureau of Land Management approved assignment of 11 federal oil and gas leases in Nevada’s White River Valley covering about 20,000 acres. The company plans exploration and development, including possible 3D seismic and drilling. Ryder Scott was hired on June 26, 2026 to estimate resources and NPV.
3 min readBIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001310488 0001310488 2026-04-15 2026-04-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor
4 min read
